Cover Image

Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study

Abstract is missing (Short communication)

Saved in:

Bibliographic Details
Main Authors:	Takeshi Nakahara (Author), Makiko Kido-Nakahara (Author), Daisuke Onozuka (Author), Sawako Sakai (Author), Tomoko Hirose (Author), Nobutoshi Take (Author), Akiko Sugiyama (Author), Kayo Harada (Author), Gaku Tsuji (Author), Satoko Kikuchi (Author), Futoshi Kohda (Author)
Format:	Book
Published:	Medical Journals Sweden, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Case of Atrophic Dermatofibroma Overexpressing Matrix Metalloproteinase-1
by: Atsuko Yano-Takamori, et al.
Published: (2019)

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
by: Kazuhisa Furue, et al.
Published: (2017)

Induction of Semaphorin 3A by Resveratrol and Pinostilbene via Activation of the AHR-NRF2 Axis in Human Keratinocytes
by: Gaku Tsuji, et al.
Published: (2024)

Pruritus in Chronic Liver Disease: A Questionnaire Survey on 216 Patients
by: Makiko Kido-Nakahara, et al.
Published: (2018)

Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitis
by: Mohamed A. Kamal, et al.
Published: (2022)

Forskolin rapidly enhances neuron‐like morphological change of directly induced‐neuronal cells from neurofibromatosis type 1 patients
by: Noriaki Sagata, et al.
Published: (2020)

Remote rehabilitation for patients with COVID-19
by: Tomoko Sakai, et al.
Published: (2020)

Dupilumab: Mechanism of action, clinical, and translational science
by: Marc R. McCann, et al.
Published: (2024)

Antioxidative Phytochemicals Accelerate Epidermal Terminal Differentiation via the AHR-OVOL1 Pathway: Implications for Atopic Dermatitis
by: Masutaka Furue, et al.
Published: (2018)

Multiple orthokeratinized odontogenic cysts: clinical, pathological, and genetic characteristics
by: Sawako Ono, et al.
Published: (2022)

Impact of physicians' clinical experience and workplace on patients' care of urticaria in Japan: A sub‐analysis of a nation‐wide cross‐sectional web questionnaire survey
by: Shunsuke Takahagi, et al.
Published: (2022)

Real‐world clinical practice of chronic inducible urticaria and urticaria due to type I allergy or intolerance in Japan: A nation‐wide cross‐sectional web questionnaire survey
by: Shunsuke Takahagi, et al.
Published: (2019)

Choosing the optimal therapeutic strategy for placental polyps using power Doppler color scoring: Transarterial embolization followed by hysteroscopic resection or expectant management?
by: Masahiko Mori, et al.
Published: (2016)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
by: Marco Ferrari, et al.
Published: (2023)

Th e clinical-economic analysis of Dupilumab in severe asthma
by: I. S. Krysanov, et al.
Published: (2021)

Histological Protection by Donepezil Against Neurodegeneration Induced by Ischemia-Reperfusion in the Rat Retina
by: Kenji Sakamoto, et al.
Published: (2010)

Review of dupilumab-associated inflammatory arthritis: An approach to clinical analysis and management
by: Ryan Jay, BA, BS, et al.
Published: (2022)

Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024)

A case of dupilumab‐induced psoriasis‐like eruption treated with baricitinib
by: Yuki Kinoshita, et al.
Published: (2024)

Revision of the International Classification of Diseases to include standardized descriptions of multiple injuries and injury severity
by: Shinji Nakahara, et al.
Published: (2011)

Improvement effects of tapinarof on the skin barrier function in Japanese patients with atopic dermatitis
by: Atsuyuki Igarashi, et al.
Published: (2024)

Treatment of refractory prurigo nodularis with a monoclonal antibody dupilumab with surprising clinical response
by: Juliana P Alves, et al.
Published: (2023)

Clinical Improvement of Bullous Pemphigoid with Hyperkeratosis and Palmoplantar Keratoderma in Two Patients Treated with Dupilumab
by: Giulia Pascolini, et al.
Published: (2024)

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study
by: Yutaka Inaba, et al.
Published: (2022)

Dupilumab treatment of a case of asthma, chronic rhinosinusitis, and atopic dermatitis after initial benralizumab administration
by: Haruna Matsuda‐Hirose, et al.
Published: (2020)

Evaluation of a pregnancy programme to enhance older primiparas' physical and mental health and marital relationships after childbirth: A non‐randomized clinical trial
by: Kumiko Nakajima, et al.
Published: (2023)

Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab
by: Marta Elosua-González, et al.
Published: (2022)

Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
by: Jonathan I. Silverberg, et al.
Published: (2021)

Ophiasis treated with dupilumab
by: McKenna Abercrombie, DO, et al.
Published: (2021)

Dramatic deterioration or new‐onset dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid after COVID‐19 vaccination: A possible manifestation of immune reconstitution inflammatory syndrome
by: Midori Sunada, et al.
Published: (2023)

Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
by: Andrea Chiricozzi, et al.
Published: (2023)

Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
by: Kariyawasam HH, et al.
Published: (2020)

New Opportunities of Dupilumab in Achieving Disease Control in Preschool Age Patients with Atopic Dermatitis: Clinical Case
by: Julia G. Levina, et al.
Published: (2024)

Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience
by: A. Martínez-Doménech, et al.
Published: (2024)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023)

Dupilumab-induced erythema nodosum
by: Danielle E. Mustin, MEng, et al.
Published: (2022)

Pemphigoid gestationis treated with dupilumab
by: Rita E. Chen, BA, et al.
Published: (2023)

Dupilumab-associated sezary syndrome
by: Austin Hamp, et al.
Published: (2023)

Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
by: Tiago Torres, et al.
Published: (2024)